C&R Research (XKRX:359090) YoY EBITDA Growth : -56.84% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is C&R Research YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. C&R Research's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -56.84%.

C&R Research's EBITDA per Share for the three months ended in Mar. 2024 was ₩10.24.

C&R Research YoY EBITDA Growth Historical Data

The historical data trend for C&R Research's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C&R Research YoY EBITDA Growth Chart

C&R Research Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-110.16

131.41

35.98

C&R Research Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial											-13.06	116.31	-12.28	114.26	-56.84

C&R Research YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

C&R Research's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(131.757	-	96.896)	/	\| 96.896 \|
=	35.98 %

C&R Research's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(10.241	-	23.729)	/	\| 23.729 \|
=	-56.84 %

C&R Research YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of C&R Research's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

C&R Research (XKRX:359090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

412 Yeoksam-ro, C&R Building, Gangnam-gu, Seoul, KOR

Website

http://www.cnrres.com

C&R Research Inc provides a quotation on clinical trial service.

C&R Research (XKRX:359090) Headlines

No Headlines